Outline:
- Definition of Common Mental Disorders and Dual diagnosis
- Approach to Screening, Assessment, Diagnosis/Formulation, and Intervention, with discussion of principles and purpose of each step
- Practice session with PSYCHECK and MENTAL HEALTH Screening, followed by Practice with DSM-5, ICD-10, MINI and Reasons for Substance Use Scales
- Practice session of 6P's of Formulation, and putting it all together into a one pager
- Description and discussion about psychopathology and phenomenology
- Approach to Mental State Examination (MSE) by interpretations of observation, inner experiences and exploration of client's understanding of their condition.
- Discussion of use of DSM-5, ICD-1, MINI, and self-rated and observer rated scales to improve the efficiency and quality of MSE
- Practice session of risk assessment through use and understanding of HCR-20, NSSI and Suicidal risk assessment for BPD, and CASE approach
- Discussion of approach to continue enhancement of MSE and risk assessment
- Psychopharmacology, as the scientific study of use of medications in treating mental disorders.
- Neurotransmission, and the five molecular targets. Monoamine hypothesis as a simplified model to understand mental health disorders, addiction, and the mechanism of action of Psychotropics (Psychiatric medications)
- Psychopharmacology for substance use disorders and dual diagnosis
- Basic information about Attention Deficit Hyperactivity disorder medications
- Increased ability to Recognize and understand Common mental disorders and Dual diagnosis presentations.
- Ability to utilize DSM-5, ICD-10 more efficiently and accurately, as well as be ready to use their updated versions in future.
- Improved ability to develop person centred and individualized formulations, by using a Bio-Psycho-Social approach and structured 6P formulations.
- Enhanced ability to work collaboratively with clients, to recognize and formulate their presentations, as well as to understand the link between their psychological world and physical symptoms.
- Improved ability to conduct a Mental state examination (MSE) throughout the contact with your client, with focus on form as well as content, strengths as well as risks.
- Ability to utilize structured diagnostic instruments like DSM-5, ICD-1, MINI, and self-rated and observer rated scales to improve the efficiency and quality of MSE.
- Improved risk assessment through use and understanding of instruments such as the HCR-20, NSSI and Suicidal risk assessment for BPD, and CASE approach.
- Increased awareness of Psychopharmacology, Monoamine hypothesis and commonly used Psychotropics (Psychiatric medications).
- Simplified and user-friendly understanding of Neurotransmission, Molecular targets of drugs, and Neurobiology of mental disorders and addictions.
- Enhanced ability to discuss scientific information in a simplified manner with clients. Awareness of user-friendly resources, which professionals and clients can access.
- Improved ability to enhance client awareness about both prescription and over the counter (OTC) medications which are evidence based to significantly enhance success rates of treatment.